The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
3D Printed Mini-Kidneys For Toxicology Testing
Researchers have teamed up with 3D printing company Organovo to develop mini-kidneys that could speed up drug testing and help chronic kidney disease patients.
PerkinElmer, NCDS To Advance Personalized Medicine In China
PerkinElmer, Inc. has announced a new collaboration with the National Center for Drug Screening to advance personalized medicine and drug profiling in China.
Researchers Develop Drug-Screening Platform For Lou Gehrig’s Disease
Researchers in Japan have developed a new drug screening assay to study familial amyotrophic lateral sclerosis, a late-onset, fatal disorder which is also known as Lou Gehrig's disease.
A New Angle On Infertility
Scientists have found that beta-catenin plays a role in fertility, affecting the structure of both male and female sexual organs.
How Exercise Can Help Depression
Feeling blue? Exercise could boost your levels of adiponectin, thereby helping to relieve the symptoms of depression, scientists say.
Vietnam Eyes Water-Saving Tech For Rice Farms
Although alternate wetting and drying technology can reduce water usage and greenhouse gas emissions, getting rice farmers to adopt this practice could be difficult.
New Anti-Tumor Properties Of Old Bone Drugs
Drugs currently used to treat osteoporosis could also be used to treat soft tissue cancers, scientists say.
Singapore’s Top Scientists Honored at PSTA 2014
Three women and five men have been awarded Singapore's top scientific honors at the President's Science and Technology Awards 2014.
Controlling Diabetes With Cytokines
Using the cytokine IL-22 instead of insulin to manage Type 2 diabetes could mean fewer injections for patients.